Method for determination of glucose concentration in whole blood

• US 5,272,060 A
• Filed: 01/16/1992
• Issued: 12/21/1993
• Est. Priority Date: 07/13/1989
• Status: Expired due to Term

• Current Assignee: Kyoto Daiichi Kagaku Company Limited
• Original Assignee: Kyoto Daiichi Kagaku Company Limited
• Inventors: Hirose, Kazunori, Hamamoto, Katsumi
• Primary Examiner(s): Wityshyn, Michael G.
• Assistant Examiner(s): REARDON, TIMOTHY
• Application Number:
  US07/821,452
• Time in Patent Office: 705 Days
• Field of Search: 435/14, 435/25, 435/29, 436/95, 436/63
• US Class Current: 435/14
• CPC Class Codes: C12Q 1/006 for glucose
• CPC Class Codes: C12Q 1/54 involving glucose or galactose
• CPC Class Codes: Y10T 436/144444 Glucose

Abstract

There is provided a method for the determination of a glucose concentration in a whole blood utilizing a biosensor. A correction of the measured glucose concentration for dilution error introduced by the solid component of blood cells is calculated based on the change in glucose concentration measured before and after significant glucose has diffused from blood cells into the buffer used to dilute the sample. Thus, the need to centrifuge blood samples to obtain a cell-free serum sample for glucose determination is eliminated.

Claims

1. A method for the in vitro measurement of the concentration of glucose in a whole blood sample, which comprises:

A) obtaining a first whole blood sample and separating it into its serum and cellular fractions;

B) mixing samples of the separated serum and cellular fractions of step (A) in varying proportions;

C) diluting each of the samples obtained from step (B) in a vessel with a solution suitable for measuring the glucose concentration in the diluted sample;

D) obtaining a first value (Cy) of the concentration of glucose in each of said diluted samples before the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

E) obtaining a second value (Cx) of the concentration of glucose in each of said diluted samples after the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

F) creating a calibration curve relating the proportion of the whole blood sample which comprises the serum fraction (X) to the ratio of the value of the step (E) to the value of step (D) (Cx/Cy);

G) creating a calibration curve relating a conversion factor (Co/Cx), said conversion factor being the ratio of Cx when X is 100% (Co) to the Cx obtained at variable values of X, to the proportion of the whole blood volume which consists of the volume of the cellular fraction (1-X);

H) obtaining a direct relationship between the conversion factor (Co/Cx) and (Cx/Cy) by mathematically eliminating the serum fraction (X) from the calibration curves obtained in steps (F) and (G);

I) obtaining a second whole blood sample in which the glucose concentration is to be determined;

J) diluting said second whole blood sample in a solution suitable for the measurement of glucose concentration in said diluted second whole blood sample;

K) obtaining a first value of the concentration of glucose in the sample solution obtained in step (J) before the glucose contained within the cells has diffused out of the cells into the solution used to dilute the second whole blood sample;

L) obtaining a second value of the concentration of glucose in the sample solution obtained in step (J) after the glucose contained within the cells has diffused out of the cells into the solution used to dilute the second whole blood sample;

M) obtaining the ratio of Cx/Cy from the values obtained in steps (K) and (L);

N) obtaining the value for the conversion factor (Co/Cx) from the relationship obtained in step (H) with reference to the ratio Cx/Cy obtained in step (M); and

O) determining the concentration of glucose in the whole blood sample of step (I) by multiplying the value of Cx obtained in step (L) by the value of the conversion factor obtained in step (N).

2. The method of claim 1, wherein the values in steps (E) and (L) are obtained by:

EL1) diluting a standard solution of known glucose concentration in said solution suitable for measuring the glucose concentration;

EL2) measuring the value of the current output of an electrode, after the current output has reached steady state, as a function of glucose concentration in said diluted standard solution to obtain a calibration curve relating electrode current and glucose concentration; and

EL3) measuring the glucose concentration in said diluted samples by measuring the output current of the electrode and referring to the calibration curve obtained in step (EL2); and

wherein the measurements made in steps (D) and (K) are obtained by;

DK1) diluting a standard solution of known glucose concentration in said solution suitable for measuring glucose concentration;

DK2) measuring the maximum value of the first derivative with respect to time of the output current of the electrode as a function of glucose concentration in said diluted standard solution to obtain a calibration curve relating said maximum value of the first derivative and glucose concentration, wherein said derivative measurement occurs at a time shorter than the time required to reach steady state in (EL2); and

DK3) measuring the glucose concentration in the second whole blood sample by measuring the maximum value of said first derivative and referring to the calibration curve in step (DK2).

3. The method of claim 2, wherein the calibration curve in step (DK2) is made and the value of Cy is measured using the maximum value of the second, or higher, derivative with respect to time of the output current of the electrode, wherein said derivative measurement occurs at a time shorter than the time required to reach steady state in (EL2).

4. The method of claim 2, wherein said electrode is operatively linked so as to measure the rate of a glucose oxidase enzymatic reaction.

5. The method of claim 4, wherein said electrode is an oxygen electrode or a hydrogen peroxide electrode or a field effect transistor.

6. A method for the measurement of the concentration of glucose in a whole blood sample, by means of a sensor comprising a hydrogen peroxide electrode (HPE), the output of which is a function of the progress of a glucose oxidase enzymatic reaction occurring in a vessel, which comprises:

A) diluting a standard solution of defined glucose concentration in a buffer in a reaction vessel containing glucose oxidase and a HPE, and obtaining a calibration curve relating the current of the HPE, measured when the rate of hydrogen peroxide production has reached a steady state, to the concentration of glucose;

B) diluting a standard solution of defined glucose concentration with said buffer in said reaction vessel, and obtaining a calibration curve relating the maximum value of the first derivative with respect to time of the current of the HPE to the concentration of glucose;

C) obtaining a first whole blood sample and separating it into the serum and cellular fractions;

D) mixing samples of the separated fractions of step (C) in varying proportions;

E) diluting each of the samples obtained from step (D) in a buffer suitable for measuring the glucose concentration in the diluted sample;

F) obtaining a first reading in each of the diluted samples of step (E), of the current generated by the HPE after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

G) obtaining a second reading in each of the diluted samples of step (E), of the maximum value of the first derivative with respect to time of the current generated by the HPE, then converting said second reading into a second measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

H) creating a calibration curve relating the proportion of the whole blood sample which comprises the serum fraction (X) to the ratio of the measurement of step (F) to the measurement of step (G) (Cx/Cy);

I) creating a calibration curve relating a conversion factor (Co/Cx), said conversion factor being the ratio of Cx when X is 100% (Co) to the Cx obtained at variable values of X (Co/Cx) to the proportion of the whole blood volume which consists of the volume of the cellular fraction (1-X);

J) obtaining a direct relationship between the conversion factor (Co/Cx) and (Cx/Cy) by mathematically eliminating the serum fraction (X) from the calibration curves obtained in steps (H) and (I);

K) obtaining a second whole blood sample, in which the glucose concentration is to be determined, and diluting said second whole blood sample with said buffer in said reaction vessel;

L) obtaining a first reading in said whole blood sample of step (K), of the current generated by the HPE after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said second whole blood sample by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

M) obtaining a second reading in said second whole blood sample of step (K), of the maximum value of the first derivative with respect to time of the current generated by the HPE, then converting said second reading into a second measurement of the glucose concentration in said second whole blood sample by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

N) determining the conversion factor (Co/Cx) by reference to the relationship obtained in step (J) with reference to Cx and Cy obtained in steps (L) and (K), respectively; and

o) multiplying said first measurement of step (L), Cx, by the conversion factor obtained in step (N) (Co/Cx) to obtain the value of the true glucose concentration in the whole blood of step (K).

7. The method of claim 6, wherein the calibration curve in step (B) is made and the value of Cy is measured using the maximum value of the second, or higher, derivative with respect to time of the current of the HPE.

8. The method of claim 6 wherein the glucose oxidase is immobilized as part of the hydrogen peroxide electrode.

9. A method for the in vitro measurement of the concentration of glucose in a whole blood sample, which comprises:

A) obtaining a first whole blood sample and separating it into its serum and cellular fractions;

B) mixing samples of the separated serum and cellular fractions of step (A) in varying proportions;

C) diluting each of the samples obtained from step (B) in a vessel with a solution suitable for measuring the glucose concentration in the diluted sample;

D) obtaining a first value (Cy) of the concentration of glucose in each of said diluted samples before the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

E) obtaining a first value (Cx) of the concentration of glucose in each of said diluted samples after the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

F) creating a calibration curve relating the proportion of the whole blood sample which comprises the serum fraction (X) to the ratio of the value of step (E) to the value of step (D) (Cx/Cy);

G) creating a calibration curve relating a conversion factor (Co/Cy), said conversion factor being the ratio of Cy when X is 100% (Co) to the Cy obtained at variable values of X, to the proportion of the whole blood volume which consists of the volume of the cellular fraction (1-X);

H) obtaining a direct relationship between the conversion factor (Co/Cy) and (Cx/Cy) by mathematically eliminating the serum fraction (X) from the calibration curves obtained in steps (F) and (G);

I) obtaining a second whole blood sample in which the glucose concentration is to be determined;

J) diluting said second whole blood sample in a solution suitable for the measurement of glucose concentration in said diluted second whole blood sample;

K) obtaining a first value (Cy) of the concentration of glucose in the sample solution obtained in step (J) before the glucose contained within the cells has diffused out of the cells into the solution used to dilute the second whole blood sample;

L) obtaining a second value (Cx) of the concentration of glucose in the sample solution obtained in step (J) after the glucose contained within the cells has diffused out of the cells into the solution used to dilute the second whole blood sample;

M) obtaining the ratio of Cx/Cy from the values obtained in steps (K) and (L);

N) obtaining the value for the conversion factor (Co/Cy) from the relationship obtained in step (H) with reference to the ratio Cx/Cy obtained in step (M); and

O) determining the concentration of glucose in the whole blood sample of step (I) by multiplying the value of Cy obtained in step (K) by the value of the conversion factor obtained in step (N).

10. The method of claim 9, wherein the values in steps (E) and (L) are obtained by:

EL1) diluting a standard solution of known glucose concentration in said solution suitable for measuring the glucose concentration;

EL2) measuring the value of the current output of an electrode, after the current output has reached steady state, as a function of glucose concentration in said diluted standard solution to obtain a calibration curve relating electrode current and glucose concentration; and

EL3) measuring the glucose concentration in said diluted samples by measuring the output current of the electrode and referring to the calibration curve obtained in step (EL2); and

wherein the measurements made in steps (D) and (K) are obtained by;

DK1) diluting a standard solution of known glucose concentration in said solution suitable for measuring glucose concentration;

DK2) measuring the maximum value of the first derivative with respect to time of the output current of the electrode as a function of glucose concentration in said diluted standard solution to obtain a calibration curve relating said maximum value of the first derivative and glucose concentration, wherein said derivative measurement occurs at a time shorter than the time required to reach steady state in (EL2); and

DK3) measuring the glucose concentration in the second whole blood sample by measuring the maximum value of said first derivative and referring to the calibration curve in step (DK2).

11. The method of claim 10, wherein the calibration curve in step (DK2) is made and the value of Cy is measured using the maximum value of the second, or higher, derivative with respect to time of the output current of the electrode, wherein said derivative measurement occurs at a time shorter than the time

12. The method of claim 10, wherein said electrode is operatively linked so as to measure the rate of a glucose oxidase enzymatic reaction.

13. The method of claim 12, wherein the electrode is an oxygen electrode or a hydrogen peroxide electrode or a field effect transistor.

14. The method of claim 12, wherein said glucose oxidase enzyme is immobilized on a membrane surface.

15. A method for the measurement of the concentration of glucose in a whole blood sample, by means of a sensor, the output of which is a function of the progress of a glucose oxidase enzymatic reaction occurring in a vessel, which comprises:

A) diluting a standard solution of defined glucose concentration with a buffer in a reaction vessel containing glucose oxidase and the sensor, and obtaining a calibration curve relating the output of the sensor, measured when the rate of hydrogen peroxide production has reached a steady state, to the concentration of glucose;

B) diluting a standard solution of defined glucose concentration with said buffer in said reaction vessel, and obtaining a calibration curve relating the maximum value of the first derivative with respect to time of the output of the sensor to the concentration of glucose;

C) obtaining a first whole blood sample and separating it into the serum and cellular fractions;

D) mixing samples of the separated fractions of step (C) in varying proportions;

E) diluting each of the samples obtained from step (D) in a buffer suitable for measuring the glucose concentration in the diluted sample;

F) obtaining a first reading in each of the diluted samples of step (E), of the output of the sensor after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

G) obtaining a second reading in each of the diluted samples of step (E), of the maximum value of the first derivative with respect to time of the output of the sensor, then converting said second reading into a second measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

H) creating a calibration curve relating the proportion of the whole blood sample which comprises the serum fraction (X) to the ratio of the measurement of step (F) to the measurement of step (G) (Cx/Cy);

I) creating a calibration curve relating a conversion factor (Co/Cx), said conversion factor being the ratio of Cx when X is 100% (Co) to the Cx obtained at variable values of X (Co/Cx) to the proportion of the whole blood volume which consists of the volume of the cellular fraction (1-X);

J) obtaining a direct relationship between the conversion factor (Co/Cx) and (Cx/Cy) by mathematically eliminating the serum fraction (X) from the calibration curves obtained in steps (H) and (I);

K) obtaining a second whole blood sample, in which the glucose concentration is to be determined, and diluting said whole blood sample with said buffer in said reaction vessel;

L) obtaining a first reading in said whole blood sample of step (K), of the output of the sensor after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said second whole blood sample by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

M) obtaining a second reading in said second whole blood sample of step (K), of the maximum value of the first derivative with respect to time of the output of the sensor, then converting said second reading into a second measurement of the glucose concentration in said second whole blood sample by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

N) determining the conversion factor (Co/Cx) by reference to the relationship obtained in step (J) with reference to Cx and Cy obtained in steps (L) and (K), respectively; and

O) multiplying said first measurement of step (L), Cx, by the conversion factor obtained in step (N) (Co/Cx) to obtain the value of the true glucose concentration in the whole blood of step (K).

16. The method of claim 15, wherein the calibration curve in step (B) is made and the value of Cy is measured using the maximum value of the second, or higher, derivative with respect to time of the output of the sensor.

17. The method of claim 15, wherein the sensor is selected from the group consisting of a hydrogen peroxide electrode, an oxygen electrode and a field effect transistor.

18. A method for the measurement of the concentration of glucose in a whole blood sample, by means of a sensor, the output of which is a function of the progress of a glucose oxidase enzymatic reaction occurring in a vessel, which comprises:

A) diluting a standard solution of defined glucose concentration with a buffer in a reaction vessel containing glucose oxidase and the sensor, and obtaining a calibration curve relating the output of the sensor, measured when the rate of hydrogen peroxide production has reached a steady state, to the concentration of glucose;

B) diluting a standard solution of defined glucose concentration with said buffer in said reaction vessel, and obtaining a calibration curve relating the maximum value of the first derivative with respect to time of the output of the sensor to the concentration of glucose;

C) obtaining a first whole blood sample and separating it into the serum and cellular fractions;

D) mixing samples of the separated fractions of step (C) in varying proportions;

E) diluting each of the samples obtained from step (D) in a buffer suitable for measuring the glucose concentration in the diluted sample;

F) obtaining a first reading in each of the diluted samples of step (E), of the output of the sensor after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

G) obtaining a second reading in each of the diluted samples of step (E), of the maximum value of the first derivative with respect to time of the output of the sensor, then converting said second reading into a second measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

H) creating a calibration curve relating the proportion of the whole blood sample which comprises the serum fraction (X) to the ratio of the measurement of step (F) to the measurement of step (G) (Cx/Cy);

I) creating a calibration curve relating a conversion factor (Co/Cy), said conversion factor being the ratio of Cy when X is 100% (Co) to the Cy obtained at variable values of X (Co/Cy) to the proportion of the whole blood volume which consists of the volume of the cellular fraction (1-X);

J) obtaining a direct relationship between the conversion factor (Co/Cy) and (Cx/Cy) by mathematically eliminating the serum fraction (X) from the calibration curves obtained in steps (H) and (I);

K) obtaining a second whole blood sample, in which the glucose concentration is to be determined, and diluting said second whole blood sample with said buffer in said reaction vessel;

L) obtaining a first reading in said whole blood sample of step (K), of the output of the sensor after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said second whole blood sample by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

M) obtaining a second reading in said second whole blood sample of step (K), of the maximum value of the first derivative with respect to time of the output of the sensor, then converting said second reading into a second measurement of the glucose concentration in said second whole blood sample by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

N) determining the conversion factor (Co/Cy) by reference to the relationship obtained in step (J) with reference to Cx and Cy obtained in steps (L) and (K), respectively; and

O) multiplying said second measurement of step (M), Cy, by the conversion factor obtained in step (N) (Co/Cy) to obtain the value of the true glucose concentration in the whole blood of step (K).

19. The method of claim 18, wherein said glucose oxidase enzyme is immobilized on a membrane surface.